InvestorsHub Logo
Followers 11
Posts 292
Boards Moderated 0
Alias Born 03/11/2011

Re: lasers post# 33457

Tuesday, 10/13/2015 6:28:46 PM

Tuesday, October 13, 2015 6:28:46 PM

Post# of 48316
I understand what the ImmunoPulse Platform is, and as a matter of fact speaking of the drug, Oncosec has an exclusive cGMP manufacturing agreement with VGXI Inc. for the production of interleukin-12 plasmid DNA. Financial terms of such agreement are not disclosed. The exclusive agreement is significant for OncoSec because it leverages VGXI’s expertise for large-scale process development and clinical manufacturing for interleukin-12 for use in OncoSec’s ElectroImmunotherapy program. Therefore, the drug will be sold and the apparatus will be licensed.